[
    {
        "title": "Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing",
        "link": "https://www.biopharmadive.com/news/amgen-shares-sink-on-obesity-drug-concerns-astrazeneca-to-spend-35b-on-m/732632/",
        "date": "N/A"
    },
    {
        "title": "AstraZeneca, Daiichi revise approval plans for Enhertu successor",
        "link": "https://www.biopharmadive.com/news/astrazeneca-daiichi-withdraw-lung-cancer-datopotamab-deruxtecan-egfr/732657/",
        "date": "N/A"
    },
    {
        "title": "On Wall Street, \u2018flat out\u2019 failure of AbbVie schizophrenia drug leaves analysts stunned",
        "link": "https://www.biopharmadive.com/news/abbvie-wall-street-cerevel-emraclidine-schizophrenia-neurocrine-neumora/732557/",
        "date": "N/A"
    }
]